Global Diagnostics PCR

Diagnostics PCR Comprehensive Study by Type (Digital PCR, Multiple PCR, Other PCR, Others), Application (Infection Disease Diagnosis, Cancer, Cardiovascular Disease (CVD), Genetic Testing, Drug Metabolism, HLA Type Test, Other Clinical Application) Players and Region - Global Market Outlook to 2028

Diagnostics PCR Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Diagnostics PCR
Diagnostics PCR (polymerase chain reaction) is a technology which is used to strengthen particular DNA in a test tube. After the reaction, amplified DNA are analyzed using thermal cycler instrument. PCR technology is gaining traction owing to growing number of regular pathogens detection. Growing technical advancement in PCR technology has led to emergence of digital PCR devices, which further bolstered the market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that American Players will contribute the maximum growth to Global Diagnostics PCR market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Alere Inc. (United States), Asuragen, Inc.(United States), Biocartis Group Nv (Belgium), Biomerieux Sa (France), Bio-Rad Laboratories, Inc. (United States), Genmark Diagnostics, Inc. (United States), Hologic, Inc. (United States), Luminex Corporation (United States) and Meridian Bioscience, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Qiagen N.V. (Germany), Quantumdx Group (United Kingdom), Roche Holding AG (Switzerland), Spartan Bioscience (Canada) and T2 Biosystems (United States).

Segmentation Overview
AMA Research has segmented the market of Global Diagnostics PCR market by Type (Digital PCR, Multiple PCR, Other PCR and Others), Application (Infection Disease Diagnosis, Cancer, Cardiovascular Disease (CVD), Genetic Testing, Drug Metabolism, HLA Type Test and Other Clinical Application) and Region.



On the basis of geography, the market of Diagnostics PCR has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Continuous Technical Advancement in PCR Technologies and Digitization of PCR Devices

Market Growth Drivers:
Growing Human Genome Project Research Activities and Increasing prevalence of Bio-marker Profiling in Disease Diagnostic

Challenges:
Implementation of Miqe Guidelines in Quantitative Real-Time PCR Experiments (MIQE) Guidelines

Restraints:
High Cost Associated with Diagnostics PCR Processes and Technical Limitations of PCR Processes in Certain Applications

Opportunities:
Development of Portable, Lab-On-Chip PCR Devices and Technology Integration with PCR Processes

Market Leaders and their expansionary development strategies
In August 2022, Bio-Rad Laboratories had acquired Curiosity Diagnostics from Scope Fluidics. The acquisition is expected to extend our reach beyond high-complexity labs into near-patient molecular diagnostics labs.
In February 2023, Thermo Fisher Scientific has launched Applied Biosystems TaqPath PCR kits infectious diseases such as multi-drug-resistant tuberculosis (MTB MDR), M. tuberculosis complex (MTB).


Key Target Audience
Diagnostics PCR Companies, End-user Industries, Market and Research Firms, Government Agencies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Digital PCR
  • Multiple PCR
  • Other PCR
  • Others
By Application
  • Infection Disease Diagnosis
  • Cancer
  • Cardiovascular Disease (CVD)
  • Genetic Testing
  • Drug Metabolism
  • HLA Type Test
  • Other Clinical Application
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Human Genome Project Research Activities
      • 3.2.2. Increasing prevalence of Bio-marker Profiling in Disease Diagnostic
    • 3.3. Market Challenges
      • 3.3.1. Implementation of Miqe Guidelines in Quantitative Real-Time PCR Experiments (MIQE) Guidelines
    • 3.4. Market Trends
      • 3.4.1. Continuous Technical Advancement in PCR Technologies
      • 3.4.2. Digitization of PCR Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diagnostics PCR, by Type, Application and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Diagnostics PCR (Value)
      • 5.2.1. Global Diagnostics PCR by: Type (Value)
        • 5.2.1.1. Digital PCR
        • 5.2.1.2. Multiple PCR
        • 5.2.1.3. Other PCR
        • 5.2.1.4. Others
      • 5.2.2. Global Diagnostics PCR by: Application (Value)
        • 5.2.2.1. Infection Disease Diagnosis
        • 5.2.2.2. Cancer
        • 5.2.2.3. Cardiovascular Disease (CVD)
        • 5.2.2.4. Genetic Testing
        • 5.2.2.5. Drug Metabolism
        • 5.2.2.6. HLA Type Test
        • 5.2.2.7. Other Clinical Application
      • 5.2.3. Global Diagnostics PCR Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Diagnostics PCR: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alere Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Asuragen, Inc.(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biocartis Group Nv (Belgium)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biomerieux Sa (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Genmark Diagnostics, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hologic, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Luminex Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Meridian Bioscience, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Diagnostics PCR Sale, by Type, Application and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Diagnostics PCR (Value)
      • 7.2.1. Global Diagnostics PCR by: Type (Value)
        • 7.2.1.1. Digital PCR
        • 7.2.1.2. Multiple PCR
        • 7.2.1.3. Other PCR
        • 7.2.1.4. Others
      • 7.2.2. Global Diagnostics PCR by: Application (Value)
        • 7.2.2.1. Infection Disease Diagnosis
        • 7.2.2.2. Cancer
        • 7.2.2.3. Cardiovascular Disease (CVD)
        • 7.2.2.4. Genetic Testing
        • 7.2.2.5. Drug Metabolism
        • 7.2.2.6. HLA Type Test
        • 7.2.2.7. Other Clinical Application
      • 7.2.3. Global Diagnostics PCR Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diagnostics PCR: by Type(USD Million)
  • Table 2. Diagnostics PCR Digital PCR , by Region USD Million (2017-2022)
  • Table 3. Diagnostics PCR Multiple PCR , by Region USD Million (2017-2022)
  • Table 4. Diagnostics PCR Other PCR , by Region USD Million (2017-2022)
  • Table 5. Diagnostics PCR Others , by Region USD Million (2017-2022)
  • Table 6. Diagnostics PCR: by Application(USD Million)
  • Table 7. Diagnostics PCR Infection Disease Diagnosis , by Region USD Million (2017-2022)
  • Table 8. Diagnostics PCR Cancer , by Region USD Million (2017-2022)
  • Table 9. Diagnostics PCR Cardiovascular Disease (CVD) , by Region USD Million (2017-2022)
  • Table 10. Diagnostics PCR Genetic Testing , by Region USD Million (2017-2022)
  • Table 11. Diagnostics PCR Drug Metabolism , by Region USD Million (2017-2022)
  • Table 12. Diagnostics PCR HLA Type Test , by Region USD Million (2017-2022)
  • Table 13. Diagnostics PCR Other Clinical Application , by Region USD Million (2017-2022)
  • Table 14. South America Diagnostics PCR, by Country USD Million (2017-2022)
  • Table 15. South America Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 16. South America Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 17. Brazil Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 18. Brazil Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 19. Argentina Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 20. Argentina Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 21. Rest of South America Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 22. Rest of South America Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 23. Asia Pacific Diagnostics PCR, by Country USD Million (2017-2022)
  • Table 24. Asia Pacific Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 25. Asia Pacific Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 26. China Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 27. China Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 28. Japan Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 29. Japan Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 30. India Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 31. India Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 32. South Korea Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 33. South Korea Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 34. Taiwan Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 35. Taiwan Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 36. Australia Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 37. Australia Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 38. Rest of Asia-Pacific Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 39. Rest of Asia-Pacific Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 40. Europe Diagnostics PCR, by Country USD Million (2017-2022)
  • Table 41. Europe Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 42. Europe Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 43. Germany Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 44. Germany Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 45. France Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 46. France Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 47. Italy Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 48. Italy Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 49. United Kingdom Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 50. United Kingdom Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 51. Netherlands Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 52. Netherlands Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 53. Rest of Europe Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 54. Rest of Europe Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 55. MEA Diagnostics PCR, by Country USD Million (2017-2022)
  • Table 56. MEA Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 57. MEA Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 58. Middle East Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 59. Middle East Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 60. Africa Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 61. Africa Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 62. North America Diagnostics PCR, by Country USD Million (2017-2022)
  • Table 63. North America Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 64. North America Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 65. United States Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 66. United States Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 67. Canada Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 68. Canada Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 69. Mexico Diagnostics PCR, by Type USD Million (2017-2022)
  • Table 70. Mexico Diagnostics PCR, by Application USD Million (2017-2022)
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Diagnostics PCR: by Type(USD Million)
  • Table 83. Diagnostics PCR Digital PCR , by Region USD Million (2023-2028)
  • Table 84. Diagnostics PCR Multiple PCR , by Region USD Million (2023-2028)
  • Table 85. Diagnostics PCR Other PCR , by Region USD Million (2023-2028)
  • Table 86. Diagnostics PCR Others , by Region USD Million (2023-2028)
  • Table 87. Diagnostics PCR: by Application(USD Million)
  • Table 88. Diagnostics PCR Infection Disease Diagnosis , by Region USD Million (2023-2028)
  • Table 89. Diagnostics PCR Cancer , by Region USD Million (2023-2028)
  • Table 90. Diagnostics PCR Cardiovascular Disease (CVD) , by Region USD Million (2023-2028)
  • Table 91. Diagnostics PCR Genetic Testing , by Region USD Million (2023-2028)
  • Table 92. Diagnostics PCR Drug Metabolism , by Region USD Million (2023-2028)
  • Table 93. Diagnostics PCR HLA Type Test , by Region USD Million (2023-2028)
  • Table 94. Diagnostics PCR Other Clinical Application , by Region USD Million (2023-2028)
  • Table 95. South America Diagnostics PCR, by Country USD Million (2023-2028)
  • Table 96. South America Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 97. South America Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 98. Brazil Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 99. Brazil Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 100. Argentina Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 101. Argentina Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 102. Rest of South America Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 103. Rest of South America Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 104. Asia Pacific Diagnostics PCR, by Country USD Million (2023-2028)
  • Table 105. Asia Pacific Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 106. Asia Pacific Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 107. China Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 108. China Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 109. Japan Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 110. Japan Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 111. India Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 112. India Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 113. South Korea Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 114. South Korea Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 115. Taiwan Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 116. Taiwan Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 117. Australia Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 118. Australia Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 119. Rest of Asia-Pacific Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 120. Rest of Asia-Pacific Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 121. Europe Diagnostics PCR, by Country USD Million (2023-2028)
  • Table 122. Europe Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 123. Europe Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 124. Germany Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 125. Germany Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 126. France Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 127. France Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 128. Italy Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 129. Italy Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 130. United Kingdom Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 131. United Kingdom Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 132. Netherlands Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 133. Netherlands Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 134. Rest of Europe Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 135. Rest of Europe Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 136. MEA Diagnostics PCR, by Country USD Million (2023-2028)
  • Table 137. MEA Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 138. MEA Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 139. Middle East Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 140. Middle East Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 141. Africa Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 142. Africa Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 143. North America Diagnostics PCR, by Country USD Million (2023-2028)
  • Table 144. North America Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 145. North America Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 146. United States Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 147. United States Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 148. Canada Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 149. Canada Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 150. Mexico Diagnostics PCR, by Type USD Million (2023-2028)
  • Table 151. Mexico Diagnostics PCR, by Application USD Million (2023-2028)
  • Table 152. Research Programs/Design for This Report
  • Table 153. Key Data Information from Secondary Sources
  • Table 154. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diagnostics PCR: by Type USD Million (2017-2022)
  • Figure 5. Global Diagnostics PCR: by Application USD Million (2017-2022)
  • Figure 6. South America Diagnostics PCR Share (%), by Country
  • Figure 7. Asia Pacific Diagnostics PCR Share (%), by Country
  • Figure 8. Europe Diagnostics PCR Share (%), by Country
  • Figure 9. MEA Diagnostics PCR Share (%), by Country
  • Figure 10. North America Diagnostics PCR Share (%), by Country
  • Figure 11. Global Diagnostics PCR share by Players 2022 (%)
  • Figure 12. Global Diagnostics PCR share by Players (Top 3) 2022(%)
  • Figure 13. Global Diagnostics PCR share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 17. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Agilent Technologies Inc. (United States) Revenue: by Geography 2022
  • Figure 19. Alere Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Alere Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Asuragen, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 22. Asuragen, Inc.(United States) Revenue: by Geography 2022
  • Figure 23. Biocartis Group Nv (Belgium) Revenue, Net Income and Gross profit
  • Figure 24. Biocartis Group Nv (Belgium) Revenue: by Geography 2022
  • Figure 25. Biomerieux Sa (France) Revenue, Net Income and Gross profit
  • Figure 26. Biomerieux Sa (France) Revenue: by Geography 2022
  • Figure 27. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Genmark Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Genmark Diagnostics, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Hologic, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Luminex Corporation (United States) Revenue: by Geography 2022
  • Figure 35. Meridian Bioscience, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Meridian Bioscience, Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Global Diagnostics PCR: by Type USD Million (2023-2028)
  • Figure 38. Global Diagnostics PCR: by Application USD Million (2023-2028)
  • Figure 39. South America Diagnostics PCR Share (%), by Country
  • Figure 40. Asia Pacific Diagnostics PCR Share (%), by Country
  • Figure 41. Europe Diagnostics PCR Share (%), by Country
  • Figure 42. MEA Diagnostics PCR Share (%), by Country
  • Figure 43. North America Diagnostics PCR Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Agilent Technologies Inc. (United States)
  • Alere Inc. (United States)
  • Asuragen, Inc.(United States)
  • Biocartis Group Nv (Belgium)
  • Biomerieux Sa (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Genmark Diagnostics, Inc. (United States)
  • Hologic, Inc. (United States)
  • Luminex Corporation (United States)
  • Meridian Bioscience, Inc. (United States)
Additional players considered in the study are as follows:
Qiagen N.V. (Germany) , Quantumdx Group (United Kingdom) , Roche Holding AG (Switzerland) , Spartan Bioscience (Canada) , T2 Biosystems (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 214 Pages 79 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Diagnostics PCR Quantitative research analysis
Global Diagnostics PCR Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Alere Inc. (United States), Asuragen, Inc.(United States), Biocartis Group Nv (Belgium), Biomerieux Sa (France), Bio-Rad Laboratories, Inc. (United States), Genmark Diagnostics, Inc. (United States), Hologic, Inc. (United States), Luminex Corporation (United States) and Meridian Bioscience, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Continuous Technical Advancement in PCR Technologies " is seen as one of major influencing trends for Diagnostics PCR Market during projected period 2022-2028.
The Diagnostics PCR market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Diagnostics PCR Report?

Have a Query? Click Here

Other Related Reports

Antimicrobial Coatings for Medical Devices Comprehensive Study by End-User (Clinics/ Diagnostic Centres, Hospitals, Ambulatory Surgical Centres, Others), Material Type (Metallic Coatings {Silver Coat...
$ 3650
Memory Impairment Treatment Comprehensive Study by Caused (Vitamin B-12 deficiency, Sleep Deprivation, Anesthesia from recent surgery, Head injury or concussion, Lack of oxygen to the brain, Others),...
$ 3500
Wrist Blood Pressure Monitor Comprehensive Study by Type (Ordinary Electronic Blood Pressure Monitor, Smart Blood Pressure Monitor), Application (Medical Use, Home Use), Technology (Wired, Wireless),...
$ 3350
Mesoporous Silica Comprehensive Study by Type (M41S (MCM-41, MCM-48, MCM-50), SBA (Santa Barbara Amorphous) {SBA-11, SBA-12, SBA-15, SBA-16}, KIT (Korea Advanced Institute of Science and Technology) ...
$ 3750
Cone Beam Computed Tomography Comprehensive Study by Type (Small FOV Systems, Medium FOV Systems, Large FOV Systems), Application (Dental, Other), Dental Application (Implantology, Oral and Maxillofa...
$ 3750
Surgery Simulators Comprehensive Study by Type (Laparoscopic, Endoscopic, Neurological, Gynecological, Cardiac, Arthroscopic), Services (Educational, Technical), End User (Academic & Research Institu...
$ 3450